Capital Investment Advisory Services, LLC Pfizer Inc Transaction History

Capital Investment Advisory Services, LLC

$972 Million
Q4 2024

A detailed history of Capital Investment Advisory Services, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Capital Investment Advisory Services, LLC holds 200,570 shares of PFE stock, worth $5.23 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

200,570

Previous 113,844 76.18%

Holding current value

$5.23 Million

Previous $3.29 Million 61.54%

% of portfolio

0.55%

Previous 0.33%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	BUY	$24.8 - $30.19 $2.15 Million - $2.62 Million	86,726 Added 76.18%	200,570 $5.32 Million
Q3 2024 Oct 30, 2024	SELL	$27.7 - $31.39 $151,242 - $171,389	-5,460 Reduced 4.58%	113,844 $3.29 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $216,730 - $253,968	8,580 Added 7.75%	119,304 $3.34 Million
Q1 2024 Apr 25, 2024	BUY	$25.89 - $29.73 $324,246 - $372,338	12,524 Added 12.75%	110,724 $3.07 Million
Q4 2023 Feb 01, 2024	BUY	$26.13 - $33.94 $285,627 - $370,998	10,931 Added 12.53%	98,200 $2.83 Million
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $593,087 - $693,259	18,482 Added 26.87%	87,269 $2.89 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $91,166 - $105,477	2,524 Added 3.81%	68,787 $2.52 Million
Q1 2023 Apr 21, 2023	SELL	$39.39 - $51.28 $145,270 - $189,120	-3,688 Reduced 5.27%	66,263 $2.7 Million
Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $22,795 - $29,757	546 Added 0.79%	69,951 $3.59 Million
Q3 2022 Oct 26, 2022	BUY	$43.76 - $53.42 $29,888 - $36,485	683 Added 0.99%	69,405 $3.04 Million
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $149,593 - $177,371	-3,215 Reduced 4.47%	68,722 $3.6 Million
Q1 2022 May 03, 2022	BUY	$45.75 - $56.69 $73,657 - $91,270	1,610 Added 2.29%	71,937 $3.72 Million
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $22,147 - $32,830	-536 Reduced 0.76%	70,327 $4.15 Million
Q3 2021 Oct 28, 2021	SELL	$39.25 - $50.42 $99,773 - $128,167	-2,542 Reduced 3.46%	70,863 $3.05 Million
Q2 2021 Jul 27, 2021	BUY	$35.91 - $40.68 $39,500 - $44,748	1,100 Added 1.52%	73,405 $2.88 Million
Q1 2021 May 05, 2021	SELL	$33.49 - $37.77 $31,882 - $35,957	-952 Reduced 1.3%	72,305 $2.62 Million
Q4 2020 Jan 25, 2021	BUY	$33.47 - $42.56 $327,437 - $416,364	9,783 Added 15.41%	73,257 $2.7 Million
Q3 2020 Oct 19, 2020	SELL	$31.75 - $37.25 $26,955 - $31,625	-849 Reduced 1.32%	63,474 $2.33 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $7,319 - $8,879	-243 Reduced 0.38%	64,323 $2.1 Million
Q1 2020 Apr 28, 2020	BUY	$27.03 - $38.62 $407,477 - $582,196	15,075 Added 30.46%	64,566 $2.11 Million
Q4 2019 Feb 04, 2020	BUY	$32.92 - $37.36 $140,700 - $159,676	4,274 Added 9.45%	49,491 $1.94 Million
Q3 2019 Oct 17, 2019	BUY	$32.49 - $42.13 $31,125 - $40,360	958 Added 2.16%	45,217 $1.63 Million
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $79,174 - $88,894	2,141 Added 5.08%	44,259 $1.9 Million
Q1 2019 Apr 23, 2019	SELL	$37.5 - $41.2 $99,225 - $109,015	-2,646 Reduced 5.91%	42,118 $1.79 Million
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $14,349 - $16,359	-373 Reduced 0.83%	44,764 $1.95 Million
Q3 2018 Oct 30, 2018	BUY	$34.47 - $41.81 $44,845 - $54,394	1,301 Added 2.97%	45,137 $1.99 Million
Q2 2018 Aug 01, 2018	SELL	$32.98 - $35.16 $23,613 - $25,174	-716 Reduced 1.61%	43,836 $1.59 Million
Q1 2018 Apr 30, 2018	BUY	$31.91 - $37.02 $309,112 - $358,612	9,687 Added 27.78%	44,552 $1.58 Million
Q4 2017 Jan 31, 2018	SELL	$33.26 - $35.29 $14,335 - $15,209	-431 Reduced 1.22%	34,865 $1.26 Million
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $1.09 Million - $1.21 Million	35,296	35,296 $1.26 Million

Others Institutions Holding PFE

# of Institutions

3,226

Shares Held

3.61B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $146B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.

Account

Capital Investment Advisory Services, LLC Pfizer Inc Transaction History